Search Results
Division of Epidemiology and Biometry, Carl von Ossietzky University, Oldenburg, Germany
Search for other papers by Julia Beckhaus in
Google Scholar
PubMed
Search for other papers by Svenja Boekhoff in
Google Scholar
PubMed
Faculty of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland
Department of Pediatrics, McMaster Children’s Hospital and McMaster University, Hamilton, Ontario, Canada
Search for other papers by Katrin Scheinemann in
Google Scholar
PubMed
Search for other papers by Freimut H Schilling in
Google Scholar
PubMed
Search for other papers by Gudrun Fleischhack in
Google Scholar
PubMed
Search for other papers by Gerhard Binder in
Google Scholar
PubMed
Search for other papers by Brigitte Bison in
Google Scholar
PubMed
Search for other papers by Torsten Pietsch in
Google Scholar
PubMed
Search for other papers by Carsten Friedrich in
Google Scholar
PubMed
Search for other papers by Hermann L Müller in
Google Scholar
PubMed
cases of congenital craniopharyngioma (cCP). We analyzed prenatal diagnostic findings, postnatal evaluation, and therapeutic interventions and outcome in these three cases of cCP. Patients and methods Patient cohorts and methods Between 2007
Search for other papers by Xiaonan Guo in
Google Scholar
PubMed
Search for other papers by Wenjing Hu in
Google Scholar
PubMed
Search for other papers by Xiaorui Lyu in
Google Scholar
PubMed
Search for other papers by Hanyuan Xu in
Google Scholar
PubMed
Search for other papers by Huijuan Zhu in
Google Scholar
PubMed
Search for other papers by Hui Pan in
Google Scholar
PubMed
Search for other papers by Linjie Wang in
Google Scholar
PubMed
Search for other papers by Hongbo Yang in
Google Scholar
PubMed
Search for other papers by Fengying Gong in
Google Scholar
PubMed
secondary deficiency of IGF-1 ( 1 ). Several studies have shown that congenital GHD is associated with an increased risk of metabolic syndromes, such as nonalcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and hyperlipidemia ( 4
Search for other papers by Vanderlan O Batista in
Google Scholar
PubMed
Search for other papers by Michael Kellner in
Google Scholar
PubMed
Search for other papers by Roberto Salvatori in
Google Scholar
PubMed
Search for other papers by Walter Lisboa in
Google Scholar
PubMed
Search for other papers by André Faro in
Google Scholar
PubMed
Search for other papers by Lucas B Santos in
Google Scholar
PubMed
Search for other papers by Enaldo V Melo in
Google Scholar
PubMed
Search for other papers by Alécia A Oliveira-Santos in
Google Scholar
PubMed
Search for other papers by Carla R P Oliveira in
Google Scholar
PubMed
Search for other papers by Viviane C Campos in
Google Scholar
PubMed
Search for other papers by Cynthia S Barros-Oliveira in
Google Scholar
PubMed
Search for other papers by Elenilde G Santos in
Google Scholar
PubMed
Search for other papers by Nathalie O Santana in
Google Scholar
PubMed
Search for other papers by Keila R Villar-Gouy in
Google Scholar
PubMed
Search for other papers by Ângela C Leal in
Google Scholar
PubMed
Search for other papers by Rivia S Amorim in
Google Scholar
PubMed
Search for other papers by Davi A Oliveira Simões in
Google Scholar
PubMed
Search for other papers by Manuel H Aguiar-Oliveira in
Google Scholar
PubMed
deficits of other pituitary hormones with inadequacy of the respective replacement therapies ( 27 ). IGHD is rare and often treated with GH replacement therapy during childhood. Therefore, the Itabaianinha cohort, with severe congenital and mostly untreated
Search for other papers by Lukas Plachy in
Google Scholar
PubMed
Search for other papers by Petra Dusatkova in
Google Scholar
PubMed
Search for other papers by Klara Maratova in
Google Scholar
PubMed
Search for other papers by Shenali Anne Amaratunga in
Google Scholar
PubMed
Search for other papers by Dana Zemkova in
Google Scholar
PubMed
Search for other papers by Vit Neuman in
Google Scholar
PubMed
Search for other papers by Stanislava Kolouskova in
Google Scholar
PubMed
Search for other papers by Barbora Obermannova in
Google Scholar
PubMed
Search for other papers by Marta Snajderova in
Google Scholar
PubMed
Search for other papers by Zdenek Sumnik in
Google Scholar
PubMed
Search for other papers by Jan Lebl in
Google Scholar
PubMed
Search for other papers by Stepanka Pruhova in
Google Scholar
PubMed
conditions such as brain tumors, trauma, infection or irradiation, and congenital forms of CPHD with a presumed genetic background ( 1 ). Pathogenic variants in more than 70 genes expressed during the prenatal development of the head, hypothalamus, and
Search for other papers by Kirsten Davidse in
Google Scholar
PubMed
Search for other papers by Anneloes van Staa in
Google Scholar
PubMed
Search for other papers by Wanda Geilvoet in
Google Scholar
PubMed
Search for other papers by Judith P van Eck in
Google Scholar
PubMed
Search for other papers by Karlijn Pellikaan in
Google Scholar
PubMed
Search for other papers by Janneke Baan in
Google Scholar
PubMed
Academic Centre for Growth, Erasmus University Medical Centre, Rotterdam, the Netherlands
Dutch Growth Research Foundation, Rotterdam, the Netherlands
Search for other papers by Anita C S Hokken-Koelega in
Google Scholar
PubMed
Search for other papers by Erica L T van den Akker in
Google Scholar
PubMed
Diabeter, National Diabetes Care and Research Centre, Rotterdam, the Netherlands
Search for other papers by Theo Sas in
Google Scholar
PubMed
Department of Paediatrics, Leiden University Medical Centre, Leiden, the Netherlands
Search for other papers by Sabine E Hannema in
Google Scholar
PubMed
Search for other papers by Aart Jan van der Lely in
Google Scholar
PubMed
Academic Centre for Growth, Erasmus University Medical Centre, Rotterdam, the Netherlands
Search for other papers by Laura C G de Graaff in
Google Scholar
PubMed
Introduction Improved diagnostics and treatment options have increased the life expectancy of children with genetic and/or congenital disorders ( 1 ). As a result, more and more patients with childhood-onset chronic conditions are making the
Office for Rare Conditions, Royal Hospital for Children & Queen Elizabeth University Hospital, Glasgow, UK
Search for other papers by S R Ali in
Google Scholar
PubMed
Search for other papers by J Bryce in
Google Scholar
PubMed
Search for other papers by A L Priego-Zurita in
Google Scholar
PubMed
Search for other papers by M Cherenko in
Google Scholar
PubMed
Search for other papers by C Smythe in
Google Scholar
PubMed
Search for other papers by T M de Rooij in
Google Scholar
PubMed
Department of Paediatric Endocrinology, Ghent University Hospital, Ghent, Belgium
Search for other papers by M Cools in
Google Scholar
PubMed
Search for other papers by T Danne in
Google Scholar
PubMed
Search for other papers by H Katugampola in
Google Scholar
PubMed
Department of Medicine & Clinical Epidemiology, Leiden University Medical Centre, Leiden, the Netherlands
Search for other papers by O M Dekkers in
Google Scholar
PubMed
Search for other papers by O Hiort in
Google Scholar
PubMed
Search for other papers by A Linglart in
Google Scholar
PubMed
Search for other papers by I Netchine in
Google Scholar
PubMed
Search for other papers by A Nordenstrom in
Google Scholar
PubMed
Search for other papers by P Attila in
Google Scholar
PubMed
Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy
Search for other papers by L Persani in
Google Scholar
PubMed
Search for other papers by N Reisch in
Google Scholar
PubMed
Search for other papers by A Smyth in
Google Scholar
PubMed
Search for other papers by Z Sumnik in
Google Scholar
PubMed
Search for other papers by D Taruscio in
Google Scholar
PubMed
Search for other papers by W E Visser in
Google Scholar
PubMed
Amsterdam Gastroenterology Endocrinology and Metabolism, Amsterdam, the Netherlands
Search for other papers by A M Pereira in
Google Scholar
PubMed
Search for other papers by N M Appelman-Dijkstra in
Google Scholar
PubMed
Office for Rare Conditions, Royal Hospital for Children & Queen Elizabeth University Hospital, Glasgow, UK
Department of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, the Netherlands
Search for other papers by S F Ahmed in
Google Scholar
PubMed
(%) <18 years ≥18 years MTG 1. Adrenal 268 6% 1470 15% Congenital adrenal hyperplasia 181 68% 267 18% Primary adrenal insufficiency 57 21% 287 20% Cortisol-producing adenomas 12 4% 222 15
Search for other papers by Ja Hye Kim in
Google Scholar
PubMed
Search for other papers by Yunha Choi in
Google Scholar
PubMed
Search for other papers by Soojin Hwang in
Google Scholar
PubMed
Search for other papers by Ji-Hee Yoon in
Google Scholar
PubMed
Search for other papers by Jieun Lee in
Google Scholar
PubMed
Search for other papers by Min Jae Kang in
Google Scholar
PubMed
Search for other papers by Gu-Hwan Kim in
Google Scholar
PubMed
Search for other papers by Han-Wook Yoo in
Google Scholar
PubMed
Search for other papers by Jin-Ho Choi in
Google Scholar
PubMed
Dodé C Dunkel L Dwyer AA Giacobini P Hardelin JP Juul A , Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism—pathogenesis, diagnosis and treatment . Nature Reviews. Endocrinology 2015 11 547
Search for other papers by Ja Hye Kim in
Google Scholar
PubMed
Search for other papers by Yunha Choi in
Google Scholar
PubMed
Search for other papers by Soojin Hwang in
Google Scholar
PubMed
Search for other papers by Gu-Hwan Kim in
Google Scholar
PubMed
Search for other papers by Han-Wook Yoo in
Google Scholar
PubMed
Search for other papers by Jin-Ho Choi in
Google Scholar
PubMed
Introduction Heterozygous CHD7 mutations can lead to the development of CHARGE syndrome, characterized by a complex range of congenital malformations including coloboma, heart defects, atresia of choana, retarded growth and development
Search for other papers by Kevin C J Yuen in
Google Scholar
PubMed
Search for other papers by Gudmundur Johannsson in
Google Scholar
PubMed
Search for other papers by Ken K Y Ho in
Google Scholar
PubMed
Search for other papers by Bradley S Miller in
Google Scholar
PubMed
Search for other papers by Ignacio Bergada in
Google Scholar
PubMed
Search for other papers by Alan D Rogol in
Google Scholar
PubMed
). The exceptions when re-testing is generally not required are in patients with genetic/congenital defects, irreversible hypothalamic–pituitary lesions, and in those with panhypopituitarism and low serum insulin-like growth factor 1 (IGF1) levels ( 4
Search for other papers by I M A A van Roessel in
Google Scholar
PubMed
Department of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands
Endo-ERN European Reference Network on Rare endocrine conditions
Search for other papers by J P de Graaf in
Google Scholar
PubMed
Endo-ERN European Reference Network on Rare endocrine conditions
Search for other papers by N R Biermasz in
Google Scholar
PubMed
Division of Endocrinology and Metabolism, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece
Search for other papers by E Charmandari in
Google Scholar
PubMed
Search for other papers by H M van Santen in
Google Scholar
PubMed
-reported). Patients with congenital or unknown causes of HD were excluded. In the situation that the diagnoses of patients were entered at the option ‘other diagnosis’ with insufficient information to be confident of the fact that these children fulfilled the